MoneyWorks4Me

Chemo Pharma Labs - Quaterly Results

29 Jul 2024 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended June 2024, as compared to corresponding quarter of last year.Net profit of the cmpany stood at Rs. 2.48 millions for the quarter ended June 2024 a decline of -34.04% from Rs. 3.76 millions  in the same quarter last year.Operating Profit reported a sharp decline to 2.49 millions from 3.78 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 3.02 4.29 -29.60 3.02 4.29 -29.60 18.38 2.95 523.05
PBIDT 2.49 3.78 -34.13 2.49 3.78 -34.13 16.52 0.86 1820.93
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.49 3.78 -34.13 2.49 3.78 -34.13 16.52 0.86 1820.93
Depreciation 0.01 0.02 -50.00 0.01 0.02 -50.00 0.08 0.13 -38.46
PBT 2.48 3.76 -34.04 2.48 3.76 -34.04 16.44 0.73 2152.05
TAX 0.00 0.00 0.00 0.00 0.00 0.00 4.43 0.26 1603.85
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 1.69 -1.04 -262.50
PAT 2.48 3.76 -34.04 2.48 3.76 -34.04 12.01 0.47 2455.32
Equity 15.00 15.00 0.00 15.00 15.00 0.00 15.00 15.00 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..